Proinflammatory Liver Cell Provides Mechanistic Insight into Liver Cancer

Share this content:
(ChemotherapyAdvisor) – The mechanism by which liver Kupffer cells induce liver cancer has been elucidated, according to a team of US-based researchers. This conclusion is based on an article entitled “The Proinflammatory Myeloid Cell Receptor TREM-1 Controls Kupffer Cell Activation and Development of Hepatocellular Carcinoma,” which was published in Cancer Research on August 15. 

The ongoing story of how chronic inflammation drives cancer pathogenesis, tumor invasiveness, and metastasis is a long-established one. In the latest chapter, the role of chronic inflammation, with its main character in driving development of liver cancer – liver Kupffer cells – was examined.   

“Liver Kupffer cells have crucial roles in mediating the inflammatory processes that promote liver cancer, but the mechanistic basis for their contributions is not fully understood,” the investigators wrote.

To meet their aim, the investigators first showed that when Kupffer cells express the protein TREM-1, they induce inflammation in the liver. Chronic inflammation was shown to be a crucial factor in the development and progression of liver cancer.

When the researchers removed the Trem1 gene from mice, exposure to the known liver carcinogen ethylnitrosamine (DEN) did not induce tumor formation. Removal of TREM-1 also reduced activation of Kupffer cells by turning off the expression and activity of several proinflammatory mediators. Reducing TREM-1 activity altogether spared the liver from the excessive injury that is characteristic of DEN exposure.

“Together, our findings offer causal evidence that TREM-1 is a pivotal determinant of Kupffer cell activation in liver carcinogenesis, deepening mechanistic insights into how chronic inflammation underpins the development and progression of liver cancer,” the investigators concluded.


Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs